Spontaneous hydrogen-releasing nanoenzyme alleviates osteoarthritis via oxidative stress reduction and mitochondrial dysfunction reversal.
Qi Wang, Minyi Zhang, Weihao Jiang, Dejian Li, Beijie Qi, Shi Shi, Shuo Shi, Chengqing Yi · Journal of nanobiotechnology · 2025
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
Among them, the Se-HMPB@AB@COS nanozyme showed the strongest protective effect on cells, reducing the early apoptosis rate from 31.3% to 7.05% and the late apoptosis rate from 24.9% to 5.59% compared to the H₂O₂ model group, indicating the significant cytoprotective effect of the hydrogen-releasing nanozyme. This source-grounded publication contributes evidence relevant to molecular hydrogen and is retained in a transparent general research category when a more specific study design is not supported by the indexed record.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen was evaluated in this publication and summarizes the source-grounded findings below. Among them, the Se-HMPB@AB@COS nanozyme showed the strongest protective effect on cells, reducing the early apoptosis rate from 31.3% to 7.05% and the late apoptosis rate from 24.9% to 5.59% compared to the H₂O₂ model group, indicating the significant cytoprotective effect of the hydrogen-releasing nanozyme.
What the Researchers Studied
The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
TISSUE IMMUNOFLUORESCENCE STAINING: For immunofluorescence staining, the sections were dried in a 60 ℃ oven for 2 h, and then treated with 3% H₂O₂ and 0.5% Triton X-100. Among them, the Se-HMPB@AB@COS nanozyme showed the strongest protective effect on cells, reducing the early apoptosis rate from 31.3% to 7.05% and the late apoptosis rate from 24.9% to 5.59% compared to the H₂O₂ model group, indicating the significant cytoprotective effect of the hydrogen-releasing nanozyme. The authors concluded that additionally, it can deliver hydrogen therapy through drug loading, enhancing anti-oxidative stress capabilities while also protecting mitochondrial function.
Why These Findings Matter
These findings add evidence supporting molecular hydrogen's therapeutic potential within the biological process and outcomes directly measured in this publication and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
H2HUBB classifies this publication as other research and interprets only the outcomes directly supported by the source record.
Technical Study Details
H2HUBB classifies this publication as other research with other supported evidence.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.